Lancet neurology
-
Great heterogeneity exists in survival and the interval between onset of motor symptoms and dementia symptoms across synucleinopathies. We aimed to identify genetic and pathological markers that have the strongest association with these features of clinical heterogeneity in synucleinopathies. ⋯ US National Institutes of Health (National Institute on Aging and National Institute of Neurological Disorders and Stroke).